Paragon 28 Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Paragon 28 Stock Summary

Paragon 28 competes with Pulmonx Corp, Iradimed, Orthofix Medical, Neuropace, and Integer Holdings. Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado. Paragon 28 operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 343 people.

Paragon 28 Key Financial Ratios

Paragon 28 Key Balance Sheet Accounts

Paragon 28 Key Income Statement Accounts

Paragon 28 Key Cash Accounts

Paragon Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Paragon 28's current stock value. Our valuation model uses many indicators to compare Paragon 28 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Paragon 28 competition to find correlations between indicators driving Paragon 28's intrinsic value. More Info.Paragon 28 is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Paragon 28's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Paragon 28's earnings, one of the primary drivers of an investment's value.

Paragon 28's Earnings Breakdown by Geography

Paragon 28 Systematic Risk

Today, most investors in Paragon 28 Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Paragon 28's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Paragon 28 growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Paragon 28 help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Paragon 28. We use our internally-developed statistical techniques to arrive at the intrinsic value of Paragon 28 based on widely used predictive technical indicators. In general, we focus on analyzing Paragon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Paragon 28's daily price indicators and compare them against related drivers.

When running Paragon 28's price analysis, check to measure Paragon 28's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Paragon 28 is operating at the current time. Most of Paragon 28's value examination focuses on studying past and present price action to predict the probability of Paragon 28's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Paragon 28's price. Additionally, you may evaluate how the addition of Paragon 28 to your portfolios can decrease your overall portfolio volatility.